Literature DB >> 34117578

Hepatic Artery Infusion Pump (HAIP) Therapy Versus Chemotherapy in the First-Line Setting for Patients with Unresectable Intrahepatic Cholangiocarcinoma.

Alexander J Rossi1, Tahsin M Khan1, Allen J Luna1, Andrea Cercek2, William R Jarnagin3, Jonathan M Hernandez4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34117578      PMCID： PMC8720372          DOI： 10.1245/s10434-021-10279-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  6 in total

1.  A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

Authors:  W D Ensminger; A Rosowsky; V Raso; D C Levin; M Glode; S Come; G Steele; E Frei
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

3.  Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.

Authors:  W R Jarnagin; L H Schwartz; D H Gultekin; M Gönen; D Haviland; J Shia; M D'Angelica; Y Fong; R DeMatteo; A Tse; L H Blumgart; N Kemeny
Journal:  Ann Oncol       Date:  2009-06-02       Impact factor: 32.976

4.  Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study.

Authors:  Jennifer A Flemming; Jina Zhang-Salomons; Sulaiman Nanji; Christopher M Booth
Journal:  Cancer       Date:  2016-05-16       Impact factor: 6.860

5.  Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial.

Authors:  Rachna T Shroff; Milind M Javle; Lianchun Xiao; Ahmed O Kaseb; Gauri R Varadhachary; Robert A Wolff; Kanwal P S Raghav; Michiko Iwasaki; Peter Masci; Ramesh K Ramanathan; Daniel H Ahn; Tanios S Bekaii-Saab; Mitesh J Borad
Journal:  JAMA Oncol       Date:  2019-06-01       Impact factor: 31.777

6.  Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.

Authors:  Andrea Cercek; Thomas Boerner; Benjamin R Tan; Joanne F Chou; Mithat Gönen; Taryn M Boucher; Haley F Hauser; Richard K G Do; Maeve A Lowery; James J Harding; Anna M Varghese; Diane Reidy-Lagunes; Leonard Saltz; Nikolaus Schultz; T Peter Kingham; Michael I D'Angelica; Ronald P DeMatteo; Jeffrey A Drebin; Peter J Allen; Vinod P Balachandran; Kian-Huat Lim; Francisco Sanchez-Vega; Neeta Vachharajani; Maria B Majella Doyle; Ryan C Fields; William G Hawkins; Steven M Strasberg; William C Chapman; Luis A Diaz; Nancy E Kemeny; William R Jarnagin
Journal:  JAMA Oncol       Date:  2020-01-01       Impact factor: 31.777
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.